Ridgeline Wealth Planning’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.13M Buy
4,910
+547
+13% +$166K 1.35% 11
2026
Q1
$932K Sell
4,363
-593
-12% -$133K 0.68% 19
2025
Q4
$848K Sell
4,956
-658
-12% -$102K 0.61% 20
2025
Q3
$752K Sell
5,614
-863
-13% -$91.4K 0.56% 20
2025
Q2
$630K Sell
6,477
-1,422
-18% -$113K 0.52% 20
2025
Q1
$574K Buy
7,899
+105
+1% +$8.27K 0.56% 18
2024
Q4
$563K Buy
+7,794
New +$591K 0.54% 20

Other funds holding LRCX

Ridgeline Wealth Planning's LRCX Position: Q2 2026 in Review

Ridgeline Wealth Planning increased its Lam Research (LRCX) stake by 13% in Q2 2026, buying an estimated $166K and bringing the position to 4,910 shares worth $2.13M. The position accounts for 1.35% of the portfolio, ranked #11.

Ridgeline Wealth Planning first reported a position in LRCX in Q4 2024 and has held it in 7 quarters since. 3,114 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Ridgeline Wealth Planning held 4,910 shares of Lam Research worth $2.13M as of Q2 2026.
  • Ridgeline Wealth Planning bought 547 Lam Research shares in Q2 2026, an estimated $166K.
  • Lam Research made up 1.35% of Ridgeline Wealth Planning's portfolio in Q2 2026, its #11 holding.
  • Ridgeline Wealth Planning first reported a position in Lam Research in Q4 2024 and has held it in 7 quarters since.
  • 3,114 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Ridgeline Wealth Planning's 13F filing for Q2 2026, filed 24 Jul 2026.